Form D · Other Technology
MediQuire, Inc.
New York, NY · CIK 0001674060
Offering snapshot reported May 20, 2016 · SEC filing
- Reported sold
- $4.88M Offering amount: $5.38M
- Investors reported
- 16 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 4, 2016 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 20, 2016 | Initial | $4,875,348 | No comparison | 16 | SEC filing |
Offering details
- Securities
- Equity, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-263598
Includes conversion of certain indebtedness
Series A Preferred Stock and Warrants
Source: Form D, filed May 20, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Bryan Grulke | Director |
| Matthew A. King | Director |
| Klaus Koenigshausen | Director, Executive |
| Cathrin Stickley | Director |
| H. Ray Welch | Director |
Issuer details
Industry: Other Technology (See others in industry)
Address:
333 West 39 Th Street, Suite 1101
New York, NY, 10018
New York, NY, 10018